Explore our featured stock ideas and investment opportunities to make informed decisions in today's market.
View AllLatest Finepoint Capital LP Stock Portfolio
$316Million
Equity Portfolio Value
Last Reported on: 13 Feb, 2024
About Finepoint Capital LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Finepoint Capital LP reported an equity portfolio of $317 Millions as of 31 Dec, 2023.
The top stock holdings of Finepoint Capital LP are CYTK, ACAD, FOLD. The fund has invested 11.4% of it's portfolio in CYTOKINETICS INC and 7.6% of portfolio in ACADIA PHARMACEUTICALS INC.
The fund managers got completely rid off CEREVEL THERAPEUTICS HLDNG I (CERE), ARES ACQUISITION CORP (AAC) and BRIDGETOWN HOLDINGS LTD (BTWN) stocks. They significantly reduced their stock positions in HOME PLATE ACQUISITION CORP (HPLT). Finepoint Capital LP opened new stock positions in LIBERTY BROADBAND CORP (LBRDA). The fund showed a lot of confidence in some stocks as they added substantially to MOONLAKE IMMUNOTHERAPEUTICS (MLTX), TRAVERE THERAPEUTICS INC (TVTX) and MORPHIC HOLDING INC (MORF).
The top stock holdings of Finepoint Capital LP are CYTK, ACAD, FOLD. The fund has invested 11.4% of it's portfolio in CYTOKINETICS INC and 7.6% of portfolio in ACADIA PHARMACEUTICALS INC.
The fund managers got completely rid off CEREVEL THERAPEUTICS HLDNG I (CERE), ARES ACQUISITION CORP (AAC) and BRIDGETOWN HOLDINGS LTD (BTWN) stocks. They significantly reduced their stock positions in HOME PLATE ACQUISITION CORP (HPLT). Finepoint Capital LP opened new stock positions in LIBERTY BROADBAND CORP (LBRDA). The fund showed a lot of confidence in some stocks as they added substantially to MOONLAKE IMMUNOTHERAPEUTICS (MLTX), TRAVERE THERAPEUTICS INC (TVTX) and MORPHIC HOLDING INC (MORF).
New Buys
| Ticker | $ Bought |
|---|---|
| LIBERTY BROADBAND CORP | 14,865,600 |
New stocks bought by Finepoint Capital LP
Additions
| Ticker | % Inc. |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | 170 |
| TRAVERE THERAPEUTICS INC | 60.22 |
| MORPHIC HOLDING INC | 52.71 |
| RELAY THERAPEUTICS INC | 51.33 |
| REVOLUTION MEDICINES INC | 44.52 |
| ACADIA PHARMACEUTICALS INC | 38.29 |
Additions to existing portfolio by Finepoint Capital LP
Reductions
| Ticker | % Reduced |
|---|---|
| HOME PLATE ACQUISITION CORP | -51.97 |
Finepoint Capital LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| BRIDGETOWN HOLDINGS LTD | -304,300 |
| CHURCHILL CAPITAL CORP V | 0.00 |
| CEREVEL THERAPEUTICS HLDNG I | -12,297,800 |
| CHURCHILL CAPITAL CORP VI | -86,400 |
| ARES ACQUISITION CORP | -333,611 |
Finepoint Capital LP got rid off the above stocks
Current Stock Holdings of Finepoint Capital LP
Last Reported on: 13 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AAC | ARES ACQUISITION CORP | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| ACAD | ACADIA PHARMACEUTICALS INC | 7.60 | 769,653 | 24,097,800 | ADDED | 38.29 | |
| ARVN | ARVINAS INC | 6.55 | 504,700 | 20,773,500 | UNCHANGED | 0.00 | |
| ASND | ASCENDIS PHARMA A/S | 6.51 | 163,772 | 20,627,100 | UNCHANGED | 0.00 | |
| BTWN | BRIDGETOWN HOLDINGS LTD | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CCV | CHURCHILL CAPITAL CORP V | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CCVI | CHURCHILL CAPITAL CORP VI | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CDAQ | COMPASS DIGITAL ACQUISITION CORP | 0.01 | 459,906 | 22,259 | UNCHANGED | 0.00 | |
| CERE | CEREVEL THERAPEUTICS HLDNG I | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CNDA | CONCORD ACQUISITION CORP II | 0.02 | 408,333 | 53,083 | UNCHANGED | 0.00 | |
| CVII | CHURCHILL CAPITAL CORP VII | 0.02 | 548,000 | 71,295 | UNCHANGED | 0.00 | |
| CYTK | CYTOKINETICS INC | 11.37 | 431,693 | 36,042,000 | UNCHANGED | 0.00 | |
| FLAG | CALIDI BIOTHERAPEUTICS INC | 0.06 | 125,000 | 188,750 | UNCHANGED | 0.00 | |
| FLAG | CALIDI BIOTHERAPEUTICS INC | 0.01 | 655,200 | 32,760 | UNCHANGED | 0.00 | |
| FOLD | AMICUS THERAPEUTICS INC | 6.67 | 1,489,020 | 21,129,300 | UNCHANGED | 0.00 | |
| GATE | MARBLEGATE ACQUISITION CORP | 0.01 | 735,000 | 22,050 | UNCHANGED | 0.00 | |
| GLPG | GALAPAGOS NV | 5.88 | 458,659 | 18,644,500 | UNCHANGED | 0.00 | |
| HPLT | HOME PLATE ACQUISITION CORP | 6.31 | 331,416 | 20,014,200 | REDUCED | -51.97 | |
| IVCP | SWIFTMERGE ACQUISITION CORP | 0.01 | 490,000 | 20,090 | UNCHANGED | 0.00 | |
| LBRDA | LIBERTY BROADBAND CORP | 4.69 | 184,460 | 14,865,600 | NEW | ||
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 0.02 | 895,000 | 62,740 | ADDED | 170 | |
| MORF | MORPHIC HOLDING INC | 4.53 | 496,856 | 14,349,200 | ADDED | 52.71 | |
| PRTA | PROTHENA CORP PLC | 4.00 | 349,300 | 12,693,600 | UNCHANGED | 0.00 | |
| RLAY | RELAY THERAPEUTICS INC | 4.58 | 1,317,870 | 14,509,700 | ADDED | 51.33 | |
| ROSS | ROSS ACQUISITION CORP II | 0.01 | 439,666 | 24,621 | UNCHANGED | 0.00 | |
| RVMD | REVOLUTION MEDICINES INC | 5.58 | 617,100 | 17,698,400 | ADDED | 44.52 | |
| SLDB | SOLID BIOSCIENCES INC | 1.86 | 961,251 | 5,902,080 | UNCHANGED | 0.00 | |
| SRPT | SAREPTA THERAPEUTICS INC | 4.42 | 145,357 | 14,016,800 | UNCHANGED | 0.00 | |
| SWTX | SPRINGWORKS THERAPEUTICS INC | 6.41 | 556,928 | 20,327,900 | UNCHANGED | 0.00 | |
| TVTX | TRAVERE THERAPEUTICS INC | 4.07 | 1,435,320 | 12,903,500 | ADDED | 60.22 | |
| YS BIOPHARMA CO LTD | 0.00 | 489,999 | 13,279 | UNCHANGED | 0.00 |